ABBOTT LABORATORIES — Director's Dealing 2020

Feb 25, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2020-02-21

Reporting Person: LANE ANDREW H (Executive Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-21	Option (right to buy)	$87.72	A	126435	Acquired	2030-02-20	Common shares (126435)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 42,145 on February 21, 2021, 42,145 on February 21, 2022, and 42,145 on February 21, 2023.